At MedtecLIVE, which will take place virtually for the first time on 1 July, everything will revolve around the topic of financing in medical technology, with the aim of networking the players in the medical technology sector. The programme includes live streamed lectures, talks and pitches. Among others, SHS will also be present.

Heinz Jacqui (59) has been appointed Senior Advisor at SHS Gesellschaft für Beteiligungsmanagement effective June 1, 2020. By way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companies that focus on medical technology and the life sciences. Through several funds, SHS has more than EUR 300 million under management. It […]

Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console, which is indicated for the treatment of anterior STEMI patients. The new system features improvements in ease of use.

CE marking is expected for 2020 Submission at the FDA is expected for early 2021 On June 19, 2020, the Swiss Medtech company Advanced Osteotomy Tools (AOT) successfully completed the last surgery required for the first-in-man clinical study of its proprietary CARLO® device. The aim of the study was to demonstrate the performance and safety […]

FAZ reports on the SHS portfolio company Selfapy, which offers online therapies for depression, anxiety and eating disorders. This enables patients who need acute help to bridge long waiting times until a doctor’s appointment.

The M&A consultancy Clairfield and Luther Rechtsanwaltsgesellschaft prepared this informative study with the support of the German Medical Technology Association (BVMed) and the German Engineering Federation (VDMA). The study gives you an overview of the current development of medical technology in Germany, Europe, the USA and Asia: from a legal, technical and transaction-oriented perspective. Due […]

Digital healthcare Selfapy GmbH (SHS V Fund) There are lots of reasons why some people might be going through a mental crisis. Contact with family and friends can be an important support in times of crisis. Now, however, with rules for social distancing in effect, this valuable support cannot continue. The affected patients need to […]

Pharmaceutical services c-LEcta GmbH (SHS III Fund) Another important building block for successfully managing the coronavirus pandemic is the development of effective drugs and vaccines. SHS invests in pharmaceuticals suppliers that can leverage high-performance solutions to help accelerate the development of pharmaceuticals products. c-LEcta GmbH, based in Leipzig, Germany, is one of the leading industrial […]

Pharmaceutical services Single Use Support GmbH (SHS V Fund) The trip for medical substances from the production site to the patient needs to be absolutely secure – the robust products by Single Use Support (Kufstein, Austria) ensure all-round protection of bagged liquid medicines: During filling, freezing, thawing, storage and transportation. A leading US biotech company […]

Medical technology TNI Medical AG (SHS III Fund) The availability of sufficient ventilatory support capacity for COVID-19 patients is an extremely critical issue for most of the healthcare systems worldwide. Products by TNI Medical AG, of Würzburg, Germany, contribute to this effort. The innovative technology developed by TNI for the non-invasive ventilatory support (high-flow therapy) […]

Medical technology Novo Klinik-Service GmbH (SHS IV Fund) Novo Klinik-Service GmbH, headquartered in Bergheim near Cologne, Germany, develops innovative products for the fixation and stabilization of endotracheal tubes in invasively ventilated patients. Given the current situation in hospitals, safe and easy-to-use solutions are particularly welcomed by nursing staff. In order to support their lung function, […]

Diagnostics GNA Biosolutions GmbH (SHS IV Fund) Test, test and test again! Diagnostics play a critical role in combating the current coronavirus pandemic (SARS-CoV-2). The quick and comprehensive identification of infected persons is a crucial contribution to the detection and critical disruption of chains of infection. With its ultra-fast PCA (pulse-controlled amplification) technology, GNA, headquartered […]